California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.
The author of California's SB 1047, the nation's most controversial AI safety bill of 2024, is back with a new AI bill that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback